ACHE and Alzheimer disease: AChE is the main enzyme that hydrolyzes ACh; however, the effectiveness of acetylcholinesterase inhibitors (AChEIs) in treating ongoing AD may be limited by significant neuronal damage and the substantial, often irreversible, loss of AChE activity (>90%).